Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996112 · ClinicalTrials.gov registry record
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
A clinical trial of Methicillin-resistant Staphylococcus Aureus, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 4,518
- Enrollment target
- 1
- Study location
NCT00996112 is a study of Methicillin-resistant Staphylococcus Aureus that has completed, run by University of Colorado, Denver. The registered enrollment target is 4,518 participants, below the 15,001-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00996112, a study of Methicillin-resistant Staphylococcus Aureus, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 4,518 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to further the investigators' understanding of community acquired methicillin-resistant Staph Aureus (CA-MRSA) and treatment of it by developing real-world sustainable strategies consistent with existing guidelines on treatment of CA-MRSA from the Centers for Disease Control and Prevention (CDC) and test these strategies in busy primary care settings.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,518 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00996112
The ClinicalTrials.gov registry entry for NCT00996112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,518 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 15,001-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (70% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methicillin-resistant Staphylococcus Aureus appearing as the primary indexed condition, and to 0 interventions.
NCT00996112 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT00996112 about?
NCT00996112 is a clinical study titled "Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections". The goal of this study is to further the investigators' understanding of community acquired methicillin-resistant Staph Aureus (CA-MRSA) and treatment of it by developing real-world sustainable strategies consistent with existing guidelines on treatment of CA-MRSA from the Centers for Disease Contro...
What is the current status of trial NCT00996112?
This trial is currently completed. The enrollment target is 4,518 participants. The study started on 2009-10. Estimated completion is 2010-08.
What conditions does trial NCT00996112 study?
This clinical trial studies the following conditions: Methicillin-resistant Staphylococcus Aureus.
Who is sponsoring clinical trial NCT00996112?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00996112 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methicillin-resistant Staphylococcus Aureus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PMT for MDRO Decolonization
RECRUITING · Phase 2
-
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
RECRUITING · Phase 4
-
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
COMPLETED
-
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
COMPLETED · NA
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.